Physician profile
George Wayne
NPI 1356791776
$5,313.02
in general payments reported to CMS, 2019-2025
33 companies · $1,171 in 2025
The $1,171 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $80.07 · 2021: $436 · 2022: $659 · 2023: $1,307 · 2024: $1,428 · 2025: $1,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,170 · Travel and Lodging: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,169.65 |
| Travel and Lodging | $736.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,925.53 | 2019-2025 | Tactra, Ams 700, Spaceoar Vue System - 10ml |
| Coloplast Corp | $899.36 | 2022-2025 | Titan, Speedicath |
| Edap Technomed INC | $283.46 | 2023 | |
| Koelis INC. | $248.52 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $200.58 | 2023-2025 | Prolaris, Myrisk |
| Laborie Medical Technologies Corp. | $169.23 | 2023-2025 | Urgent Pc Neuromodulation System |
| Axogen | $156.74 | 2025 | |
| Procept Biorobotics Corporation | $153.58 | 2025 | |
| Endo Pharmaceuticals INC. | $140.11 | 2021-2024 | Xiaflex |
| Pfizer INC. | $138.11 | 2021-2022 | |
| Ethicon US, LLC | $124.20 | 2021 | |
| Endo USA, INC. | $101.12 | 2024-2025 | Xiaflex |
| Merck Sharp & Dohme LLC | $81.78 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $70.88 | 2024-2025 | Gemtesa |
| Astrazeneca Pharmaceuticals Lp | $63.65 | 2021-2025 | Wainua |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $61.11 | 2021 | |
| Antares Pharma, INC. | $48.82 | 2021-2022 | |
| Exact Sciences Corporation | $46.67 | 2023-2025 | Cologuard Collection Kit |
| Urovant Sciences INC | $45.79 | 2022 | |
| Janssen Biotech, INC. | $41.24 | 2025 | Erleada |
| Astellas Pharma US INC | $38.85 | 2021-2023 | Myrbetriq |
| Hollister Incorporated | $37.70 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $35.83 | 2019 | |
| Madrigal Pharmaceuticals | $30.79 | 2025 | Rezdiffra |
| Valencia Technologies Corporation | $26.03 | 2025 | Ecoin Device Kit |
| Tolmar, INC. | $20.05 | 2025 | Jatenzo, Eligard |
| Abbvie INC. | $19.95 | 2023 | Botox |
| Verity Pharmaceuticals INC. | $19.53 | 2024 | Trelstar |
| Axonics, INC. | $19.17 | 2023 | Axonics |
| Travere Therapeutics, INC. | $17.66 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $17.37 | 2021 | |
| Clarus Therapeutics INC. | $15.48 | 2021 | |
| Olympus America INC. | $14.13 | 2023 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Wayne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.